Dr. Ulrich Wandschneider

Dr. Ulrich Wandschneider currently serves as a member of the supervisory board at BioNTech SE and holds various influential positions including Aufsichtsratsmitglied at Marienhaus-Gruppe and Beiratsvorsitzender at Oberberg Kliniken. Dr. Wandschneider has extensive experience in the healthcare sector, having been the CEO and Chairman of the Supervisory Board at Asklepios and Chairman of the Supervisory Board and CEO at MEDICLIN AG. Additionally, Dr. Wandschneider was an Operating Partner at Trilantic Europe and served as a Board Member at Vanguard AG - Medical Remanufacturing. With a strong background in consulting, Dr. Wandschneider also held leadership roles at Deloitte Consulting and Arthur Andersen. Dr. Wandschneider has been active in the Hanns Martin Schleyer Foundation as a member of the Board of Trustees since 2011.